Toyota recalling 94,000 Sienna minivans over brake lamp issue.
AFP (12/14) reports, "Toyota on Monday recalled some 94,000 of its 2011 Sienna minivans in the United States to replace a brake bracket that could get stuck. Citing a light problem that could cause unwanted brake activation, Toyota announced it was just the latest in a series of recalls."
The AP (12/14, Thomas) reports the company explained that "a driver's foot could hit the switch bracket and deform it while applying the parking brake pedal." The AP notes, "The switch bracket is welded on to the left side of the brake pedal assembly. The brake lamp provides a signal to indicate that the brake pedal has been depressed and illuminates the brake lights."
The USA Today (12/13, Meier) "Drive On" blog said, "Depending on the amount of damage, the brake lights could stay on or the brakes could stay partially engaged, resulting in brake drag that would increase wear and may produce 'brake noise, brake vibration, and/or illumination of the brake warning light. If this condition is not noticed and the vehicle continues to be driven, braking effectiveness could be reduced,' says Toyota."
Tuesday, December 14, 2010
Monday, December 13, 2010
Hyundai Santa Fe and Kia Sorento recalls
Hyundai, Kia recall models to repair rear brakes.The Wall Street Journal (12/12, Welsh) reported Hyundai Motor Corporation and its Kia subsidiary recalled some of its 2011 models to address braking glitches. The rear brake calipers in Hyundai's Santa Fe model and Kia's Sorento risk leaking brake fluid, which could result in the loss of brake functionality. Nearly 1,783 Santa Fe models and 7,697 Sorentos are affected.
Drug Safety--Thelin (sitaxentan)
Pfizer recalls blood pressure drug due to liver damage.
The AP (12/10, Seaman) reported, "Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin (sitaxsentan) off the market and stopping all clinical trials because the drug can cause fatal liver damage." Thelin "is sold in the European Union, Canada, and Australia as an oral treatment for severe pulmonary arterial hypertension, or high blood pressure in the pulmonary artery." Pfizer said "liver damage was a known side effect of Thelin and similar drugs...but the review uncovered a link to liver damage that was not tied to identifiable risk factors." In addition to the recall, the company "has withdrawn its filing for marketing in the United States."
According to the New York Times (12/10, Wilson) "Prescriptions" blog, Pfizer is halting "clinical trials it was conducting in a years-long quest to gain approval in the United States." The Food and Drug Administration "has rejected applications to market the drug in the United States at least three times in recent years, out of concern that the risks outweighed the drug's effectiveness -- concerns apparently validated by Pfizer's announcement."
The AP (12/10, Seaman) reported, "Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin (sitaxsentan) off the market and stopping all clinical trials because the drug can cause fatal liver damage." Thelin "is sold in the European Union, Canada, and Australia as an oral treatment for severe pulmonary arterial hypertension, or high blood pressure in the pulmonary artery." Pfizer said "liver damage was a known side effect of Thelin and similar drugs...but the review uncovered a link to liver damage that was not tied to identifiable risk factors." In addition to the recall, the company "has withdrawn its filing for marketing in the United States."
According to the New York Times (12/10, Wilson) "Prescriptions" blog, Pfizer is halting "clinical trials it was conducting in a years-long quest to gain approval in the United States." The Food and Drug Administration "has rejected applications to market the drug in the United States at least three times in recent years, out of concern that the risks outweighed the drug's effectiveness -- concerns apparently validated by Pfizer's announcement."
Friday, December 10, 2010
Tuesday, December 7, 2010
Volvo Recalls 2009-2011 S40, S60 Sedans and XC60 for Seat Installation Flaws
Volvo recalls 7,420 vehicles to repair seat installation flaw.
The Wall Street Journal (12/6, Welsh) reported Volvo is recalling its S40 and S60 sedans and V50 station wagons from 2009 through 2011, as well as its XC60 crossovers from 2010 and 2011 to address passenger seat installation errors. According to Volvo, the improper installment of the seat's front rails may enable the seat to move farther ahead then intended, increasing the likelihood of injury during a crash. The recall involves 7,420 cars.
The Wall Street Journal (12/6, Welsh) reported Volvo is recalling its S40 and S60 sedans and V50 station wagons from 2009 through 2011, as well as its XC60 crossovers from 2010 and 2011 to address passenger seat installation errors. According to Volvo, the improper installment of the seat's front rails may enable the seat to move farther ahead then intended, increasing the likelihood of injury during a crash. The recall involves 7,420 cars.
Thursday, December 2, 2010
Report Details how Civil Justice System Helps Improve Child Toy Safety
The report, titled, “Playing with Safety: Dangerous Toys and the Role of America’s Civil Justice System,” details how the public learned about little known dangers hidden in today’s popular toys.
Protecting Consumer Rights and Access to Our Jury System
This is a movie premiering at the Sundance Film festival that helps to try and educate the public how they are losing their precious rights.
http://www.protectconsumerjustice.org/dealing-with-the-misperceptions-of-the-mcdonalds-coffee-case.html
http://www.protectconsumerjustice.org/dealing-with-the-misperceptions-of-the-mcdonalds-coffee-case.html
Subscribe to:
Posts (Atom)